Atossa Therapeutics (ATOS) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.05
-0.71
-0.38
-0.04

Details

Expected EPS
-0.975
Actual EPS
-1.05
Surprise EPS
-0.08
Surprise Percent
+7.69%

Description

Atossa Therapeutics (ATOS) has reported earnings of -1.05 per share for Q4 2025.

0 Comments

Share your thoughts